As a pharmaceutical or device manufacturer, technology company, or information provider, you can count on ISMP for invaluable input and education on medication safety-related issues that impact millions of patients and healthcare professionals. The featured offerings at right will connect you to ISMP resources on medication error prevention, including expert speakers, symposia management services, and publications.

In addition, Med-ERRS®, a wholly-owned subsidiary of ISMP, is uniquely suited to assist global pharmaceutical, biotechnology and healthcare technology companies in evaluating the safety of their products. From trademarks, packaging and label designs to risk management, Med-ERRS® works with pharmaceutical and healthcare industry professionals who specialize in trademark development, trademark law, regulatory affairs and drug safety. 


This month's main topic: Ongoing Confusion with Different Products that Use the Ellipta Inhaler Device
This week's featured article: Survey Results: Smart Pump Data Analytics - Pump Metrics that Should Be Monitored to Improve Safety
This issues's featured article: Mix-ups between Five Different Inhalers that All Include "Ellipta" as Part of Their Brand Names
This list includes selected proprietary names that contain a suffix, along with the meaning of the suffix.
Problem: Nebulization of inhaled medications provides an excellent delivery route for the treatment of both pulmonary and nonpulmonary conditions. The mist is easily inhaled by breathing normally, without requiring coordinated breaths to inhale the medication (as required with metered dose inhalers)...